A Case of Long-Term Survival after Checkpoint Inhibitor Pneumonitis in a Patient with Squamous Cell Lung Cancer

The management of grade 1 checkpoint inhibitor pneumonitis (CIP) is to withhold immune checkpoint inhibitors; however, the natural history of this condition is unknown. We herein report the case of a woman with squamous cell lung cancer who was a long-term survivor after CIP. After 4 rounds of treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashinuma, Hironori, Mizuno, Satoko, Yoshida, Yasushi, Shingyoji, Masato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948310/
https://www.ncbi.nlm.nih.gov/pubmed/31949964
http://dx.doi.org/10.1155/2019/4836404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948310/
https://www.ncbi.nlm.nih.gov/pubmed/31949964
http://dx.doi.org/10.1155/2019/4836404

Ejemplares similares